Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Clinical status of capecitabine in the treatment of breast cancer
William J. Gradishar
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical status of capecitabine in the treatment of breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Breast Cancer
100%
Capecitabine
100%
Therapeutic Procedure
60%
Development
40%
Chemotherapy
40%
Combination Therapy
40%
Patient
40%
Symptomatic Treatment
20%
Cancer Cell
20%
Bioavailability
20%
Fluoropyrimidine
20%
Chemotherapeutic Agent
20%
Symptom
20%
Drug
20%
Medication
20%
INIS
cancer
100%
breasts
100%
patients
40%
data
20%
drugs
20%
therapy
20%
reviews
20%
symptoms
20%
chemotherapy
20%
biological availability
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Capecitabine
100%
Bioavailability
20%
Molecular Target
20%
Fluoropyrimidine
20%
Drug
20%
Symptom
20%